海尔生物：公司外延并购工作正在有序推进

Group 1 - The core viewpoint of the article is that Haier Biomedical emphasizes external mergers and acquisitions as a crucial development strategy for the company [1] - The company is currently advancing its external merger and acquisition efforts in an orderly manner [1] - Haier Biomedical aims to carefully select companies with high technological barriers and significant growth potential to strengthen its core business [1]